Atypical Parkinsonism (also known as Parkinson-plus syndromes) refers to a group of neurodegenerative disorders that share some features with Parkinson’s disease but have distinct pathology, faster progression, and poorer response to levodopa.

High-Level Summary

• Encompasses Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), Corticobasal Degeneration (CBD), and Dementia with Lewy Bodies (DLB) as the most common forms
• Earlier falls, autonomic dysfunction, symmetrical symptoms, and poor levodopa response are red flags
• Significantly shorter life expectancy compared to idiopathic Parkinson’s disease
• No disease-modifying treatments currently approved

Challenges in Differential Diagnosis

Accurate diagnosis is difficult in early stages because symptoms overlap significantly with Parkinson’s disease and with each other. Up to 20-30% of patients initially diagnosed with Parkinson’s disease are later found to have an atypical parkinsonian syndrome at autopsy. Early and precise diagnosis is critical for prognosis counseling, care planning, and enrollment in clinical trials.

The Urgent Need for Timely Diagnosis

Patients and families face years of uncertainty while the disease progresses rapidly. Early specialist referral and use of emerging diagnostic tools (biomarkers, advanced imaging, etc.) can dramatically improve outcomes and access to new therapies currently in development.